Bicara Therapeutics Inc.
Bicara Therapeutics Inc. scores highest on Torque (67) and lowest on Earnings (20). Its PosiPenta is 41.23 out of 100, around the middle of similar companies.
On the Penta Grid this week, Bicara Therapeutics Inc. is Grid #495 of 836 in the Healthcare sector in United States, and Grid #2,758 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | 41.23 | 25 | 20 | 49 | 67 | 44 |
| STAAR Surgical Company | 55.20 | 24 | 87 | 58 | 63 | 43 |
| PROCEPT BioRobotics Corporation | 40.31 | 22 | 41 | 35 | 50 | 53 |
| Lumexa Imaging Holdings, Inc. | 50.32 | 31 | 80 | 58 | 12 | 70 |
| Teladoc Health, Inc. | 44.37 | 42 | 45 | 54 | 46 | 34 |
| Avalyn Pharma Inc. | 38.29 | 24 | 25 | 45 | 61 | 37 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -5.45 |
| P/B ratio | 2.37 |
EEarnings
| Trailing EPS | ₹-291.72 |
| Forward EPS | ₹-333.31 |
NNitro
| Price | 1589.32 |
| 52-week high | 2935.22 |
| 52-week low | 1297.59 |
| Fall from 52-week high | 45.9% |
TTorque
| Return on equity (ROE) | -41.01% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | -0.69 |
| Market cap | ₹10,516 Cr |
| Insider holding | 10.07% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Bicara Therapeutics Inc.'s PosiPenta score?
Bicara Therapeutics Inc.'s PosiPenta is 41.23 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Bicara Therapeutics Inc. stand on the Penta Grid?
On the Penta Grid this week, Bicara Therapeutics Inc. is Grid #495 of 836 in the Healthcare sector in United States, and Grid #2,758 of 3,999 in United States.
Which PosiPenta pillar is strongest for Bicara Therapeutics Inc.?
Torque (durability), with a score of 67 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Bicara Therapeutics Inc.?
Earnings (growth), with a score of 20 out of 100: weaker than most similar companies.
Has Bicara Therapeutics Inc.'s PosiPenta changed since last week?
Yes, it rose 2.67 points, from 38.56 to 41.23.
PositoAI is for research and education only and is not investment advice.